SCHEMBL6696444

SCHEMBL6696444

Cc1c(Nc2ccc3ccccc3c2)ccc(Nc2ccc3ccccc3c2)c1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
CYP3A4 P08684 2/20 0.50
HSD17B10 Q99714 2/20 0.50
HPGD P15428 2/20 0.50
HIF1A Q16665 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
MAP2K2 P36507 1/20 0.40
MAP2K1 Q02750 1/20 0.40
DHODH Q02127 1/20 0.40
RAB9A P51151 4/20 0.39
MAPT P10636 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6696006 0.88 ALDH1A1 (0.59) ALDH1A1CYP3A4HSD17B10HPGDHIF1A
SCHEMBL30574524 0.82 ALDH1A1 (0.57) ALDH1A1CYP3A4HSD17B10HPGDHIF1A
SCHEMBL23908285 0.82 ALDH1A1 (0.57) ALDH1A1CYP3A4HSD17B10HPGDHIF1A
SCHEMBL21142258 0.81 ALDH1A1 (0.52) ALDH1A1CYP3A4HSD17B10HPGDHIF1A
SCHEMBL15273014 0.78 ALDH1A1 (0.52) ALDH1A1CYP3A4HSD17B10HPGDHIF1A
SCHEMBL28690752 0.78 ALDH1A1 (0.52) ALDH1A1CYP3A4HSD17B10HPGDHIF1A
SCHEMBL17794436 0.77 ALDH1A1 (0.59) ALDH1A1CYP3A4HSD17B10HPGDHIF1A
SCHEMBL29688279 0.76 ALDH1A1 (0.68) ALDH1A1CYP3A4HSD17B10HPGDHIF1A
SCHEMBL1923372 0.76 ALDH1A1 (0.68) ALDH1A1CYP3A4HSD17B10HPGDHIF1A
SCHEMBL28651741 0.75 ALDH1A1 (0.49) ALDH1A1CYP3A4HSD17B10HPGDHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040009973-A1 Phenylenediamine derivatives N-substituted with benzyl- or heteroarylmethyl- groups 4SC AG (DE) 2004-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009973-A1 Phenylenediamine derivatives N-substituted with benzyl- or heteroarylmethyl- groups PAH, PNMT, OPRM1 ALDH1A1 458/4885CYP3A4 16/4885HSD17B10 832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.